Therapeutic evaluations by the Patented Medicine Prices Review Board
| No. of drugs that received an evaluation; classification | No. of drugs that did not receive an evaluation; reason | ||||
|---|---|---|---|---|---|
| Breakthrough or substantial improvement | Moderate, little or no improvement (evaluated before 2010) | Slight or no improvement (evaluated from 2010 onward) | Approved before 1988 | Approved from 2015 onward and not in most recent report | Other |
| 2 | 22 | 9 | 9 | 4 | 7* |
↵* One drug was not evaluated because it was approved for a second indication, for 1 the approval date unknown, and the reason there was no evaluation is unknown for the other 5.